Axa

Axa’s Anika Therapeutics ANIK Stock Holding History

Axa’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-19,200	Closed	-$634K	–	1444
2015 Q2	$634K	Sell	19,200 -2,700	-12%	-$96.3K	﹤0.01%	1037
2015 Q1	$902K	Buy	21,900 +2,200	+11%	+$88.9K	﹤0.01%	977
2014 Q4	$803K	Buy	19,700 +12,500	+174%	+$489K	﹤0.01%	1012
2014 Q3	$264K	Buy	+7,200	New	+$311K	﹤0.01%	1196
2014 Q2	–	Sell	-3,600	Closed	-$148K	–	1384
2014 Q1	$148K	Sell	3,600 -9,100	-72%	-$338K	﹤0.01%	1251
2013 Q4	$485K	Sell	12,700 -23,300	-65%	-$719K	﹤0.01%	1071
2013 Q3	$863K	Buy	36,000 +100	+0.3%	+$2.25K	﹤0.01%	898
2013 Q2	$610K	Buy	+35,900	New	+$518K	﹤0.01%	932

Other funds holding ANIK

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Thompson Siegel & Walmsley Richmond, Virginia $5.66B AUM 6.69% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return